Meningitis Outbreak

Lawmakers Seek Answers After Meningitis Outbreak

November 15, 2012

In her testimony in Washington, Mass. Health and Human Services Secretary JudyAnn Bigby called the outbreak “one of the greatest health care tragedies” in memory.

Questions Remain After Meningitis Hearings

November 15, 2012

For a closer look at Wednesday’s meningitis outbreak hearings, and what questions remain, Harvard’s Daniel Carpenter, who specializes in regulatory law, joined WBUR.

Owner Of Meningitis-Linked Pharmacy Takes Fifth

November 14, 2012
New England Compounding Center President, co-owner and Director of Pharmacy Barry Cadden is sworn in before a congressional committee on Capitol Hill Wednesday. (Susan Walsh/AP)

Barry Cadden told lawmakers he would use his Fifth Amendment right to not answer questions in order to avoid self-incrimination.

Sec. Bigby: Meningitis Outbreak A ‘Disaster’ That Was ‘Preventable’

November 14, 2012

Recently released documents show that over the past decade the state did not aggressively pursue action against the center, despite complaints.

Anger, Embarrassment At Mass. Hearing On Meningitis Outbreak

November 14, 2012

Massachusetts lawmakers grilled Patrick administration leaders and regulators about what went wrong in the oversight of a pharmacy at the center of a meningitis outbreak.

Mass. DPH: Not Clear Why Board Backed Off Penalty

November 14, 2012

In 2004, the company protested that a penalty could destroy its business, and in 2006, the pharmacy board agreed to impose far weaker action for reasons that remain unclear.

FDA Previously Questioned Work Of Framingham Pharmacy

November 13, 2012

Hearings get underway Wednesday at the Massachusetts State House and in Washington to look into the fungal meningitis outbreak that originated at a Framingham compounding pharmacy.

Report: FDA Wanted To Close Mass. Pharmacy In 2003

November 13, 2012

In 2003, the FDA suggested that the firm at the center of the meningitis outbreak be shut down but deferred to their counterparts in Mass., who let the pharmacy continue manufacturing.

FDA Finds Contamination Issues At Ameridose

November 12, 2012
Two men stand guard outside the entrance to Ameridose LLC in Westborough in this Oct. 11 file photo (Elise Amendola/AP)

Inspectors found numerous potential sources of contamination at the Westborough drug-making facility that has the same founders as the pharmacy linked to a meningitis outbreak.

Hearings To Examine Compounding Pharmacy Oversight

November 12, 2012

Three hearings in Boston and Washington, D.C. will focus on whether a deadly outbreak of fungal meningitis traced to a Framingham compounding pharmacy could have been prevented.

Mass. Pharmacy Board Director Is Fired

November 07, 2012

The director was fired for ignoring a complaint that a Framingham company linked to a deadly meningitis outbreak was shipping drugs in bulk, in violation of its state license.

Lawmakers Issue Subpoena For Director Of Pharmacy Linked To Meningitis Outbreak

November 06, 2012

The subpoena comes after Barry Cadden, co-founder of New England Compounding Center, reportedly declined to appear before Congress next week.

Framingham Pharmacy Workers Ordered To Stop Work

November 06, 2012

Regulators ordered all pharmacists and technicians who worked at the company at the center of the meningitis outbreak to stop working in the drug-compounding industry.

Tests Find Bacteria In Products Of Mass. Pharmacy

November 02, 2012

Federal regulators say that further testing has found bacteria in products made by a Framingham pharmacy linked to the deadly fungal meningitis outbreak.

Mass. Board Approves New Regulations For Compounding Pharmacies

November 01, 2012

The emergency regulations allow the state to monitor whether the specialty pharmacies are operating more like drug manufacturing facilities.

Mass. To Hold Hearings On State Health Department

November 01, 2012

Lawmakers will hold hearings looking into the Department of Public Health’s handling of the meningitis outbreak and drug lab scandal.

Sister Company Of Framingham Pharmacy Recalls Drugs

October 31, 2012

Ameridose is a sister company of New England Compounding Center, the pharmacy at the center of the meningitis outbreak.

Framingham Pharmacy In Meningitis Outbreak Touted Cleanliness

October 31, 2012

The firm sent customers a “report card” touting the cleanliness of its labs, even though internal tests showed widespread contamination.

Mass. Shuts Down Waltham Compounding Pharmacy

October 28, 2012

The Department of Public Health shut down a compounding pharmacy in Waltham after a surprise inspection prompted by the nationwide meningitis outbreak linked to a different company.

FDA: ‘Greenish Black’ Matter In Steroid Vials, Mold In NECC ‘Clean Rooms’

October 26, 2012

The FDA found mold and bacteria in two so-called “clean rooms” in the Framingham specialty pharmacy linked to the nationwide meningitis outbreak.

Most Popular